In addition, several SNPs in TCN2, CUBN, and MUT genes appeared to be more prone to the occurrence of multiple clinical manifestations, including drug resistance, hypoproteinemia, and leukopenia in PTB patients. This evidence concerns the gene CUBN and Decreased total leukocyte count.